Meeting
2015 Genitourinary Cancers Symposium
Correlation between time to prostate cancer metastasis and overall survival after androgen deprivation therapy initiation.
Authors
Lillian Werner
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Lillian Werner , Loana Valenca , Wanling Xie , Mari Nakabayashi , Philip W. Kantoff , Mark M Pomerantz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate, Penile, Testicular, and Urethral Cancers, and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 250)
DOI
10.1200/jco.2015.33.7_suppl.250
Abstract #
250
Poster Bd #
C19
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Carboplatin in metastatic castrate resistant prostate cancer: A retrospective study of heavily pretreated patients (COMPACT).
First Author: Lara Pemberton
Poster
2018 ASCO Annual Meeting
Timing of androgen deprivation therapy for prostate cancer patients after radiation: Planned combined analysis of two randomized phase 3 trials.
First Author: Andrew Loblaw
Poster
2014 Genitourinary Cancers Symposium
A predicitve algorithm for response to abiraterone in metastatic castration relapsed prostate cancer (CRPC).
First Author: Mehran Afshar
Poster
2024 ASCO Genitourinary Cancers Symposium
Impact of exposure to clinical trials and standard-of-care therapy in metastatic or recurrent prostate cancer: An update.
First Author: Grace G Kim